4//SEC Filing
Hirsch Stanley 4
Accession 0001209191-19-053413
CIK 0001606645other
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 4:11 PM ET
Size
8.2 KB
Accession
0001209191-19-053413
Insider Transaction Report
Form 4
Hirsch Stanley
Director
Transactions
- Exercise/Conversion
Ordinary Shares
2019-10-15$0.62/sh+90,000$55,800→ 150,000 total(indirect: See footnote) - Exercise/Conversion
Options
2019-10-15−90,000→ 32,500 total(indirect: See footnote)Exercise: $0.62From: 2004-01-01Exp: 2019-11-25→ Ordinary Shares (90,000 underlying)
Holdings
- 69,365
Ordinary Shares
Footnotes (2)
- [F1]Securities are held by ZEAS Technology and Science Management Ltd., a company beneficially owned by Stanley Hirsch.
- [F2]This security represents ordinary shares and restricted share units. Each restricted share unit represents a contingent right to receive one ordinary share of the issuer.
Documents
Issuer
Foamix Pharmaceuticals Ltd.
CIK 0001606645
Entity typeother
Related Parties
1- filerCIK 0001727864
Filing Metadata
- Form type
- 4
- Filed
- Oct 16, 8:00 PM ET
- Accepted
- Oct 17, 4:11 PM ET
- Size
- 8.2 KB